RAPT Therapeutics, Inc.(RAPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RAPT RAPT Therapeutics, Inc.

停牌 03-02 16:00:00 EST

58.02

+0.04

+0.07%

盘后58.02

+0.000.00%

19:35 EST

最高58.02	最低57.98	成交量1,113万
今开57.98	昨收57.98	日振幅0.07%
总市值16.80亿	流通市值14.97亿	总股本2,896万
成交额6.45亿	换手率43.11%	流通股本2,581万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RAPT","market":"US","secType":"STK","nameCN":"RAPT Therapeutics, Inc.","latestPrice":58.02,"timestamp":1772485200000,"preClose":57.98,"halted":3,"volume":11125216,"hourTrading":{"tag":"盘后","latestPrice":58.02,"preClose":58.02,"latestTime":"19:35 EST","volume":63303,"amount":3672053.9523,"timestamp":1772498123557,"change":0,"changeRate":0,"amplitude":0.002241},"delay":0,"changeRate":0.0006898930665747888,"floatShares":25807521,"shares":28960600,"eps":-11.66,"marketStatus":"停牌","change":0.04,"latestTime":"03-02 16:00:00 EST","open":57.98,"high":58.02,"low":57.98,"amount":645210283.985664,"amplitude":0.00069,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.66,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1772528400000},"marketStatusCode":0,"adr":0,"listingDate":1572494400000,"exchange":"NASDAQ","adjPreClose":57.98,"preHourTrading":{"tag":"盘前","latestPrice":57.98,"preClose":57.98,"latestTime":"09:28 EST","volume":1189,"amount":68964.38988999999,"timestamp":1772461725938,"change":0,"changeRate":0,"amplitude":0.00069},"postHourTrading":{"tag":"盘后","latestPrice":58.02,"preClose":58.02,"latestTime":"19:35 EST","volume":63303,"amount":3672053.9523,"timestamp":1772498123557,"change":0,"changeRate":0,"amplitude":0.002241},"volumeRatio":8.552991,"impliedVol":0.107,"impliedVolPercentile":0.064},"requestUrl":"/m/hq/s/RAPT","defaultTab":"news","newsList":[{"id":"1117947695","title":"Leerink Partners下调RAPT Therapeutics评级至“市场表现”，目标价降至58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1117947695","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117947695?lang=zh_cn&edition=full","pubTime":"2026-01-21 11:53","pubTimestamp":1768967598,"startTime":"0","endTime":"0","summary":"Leerink Partners将RAPT Therapeutics, Inc.的股票评级从“跑赢大盘”下调至“市场表现”，同时将其目标股价从60美元调降至58美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT","BK4139"],"gpt_icon":0},{"id":"1121681286","title":"美股开盘 | 三大指数大幅低开，英伟达、谷歌跌超2%；RAPT涨超63%，联电涨近14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121681286","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121681286?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:31","pubTimestamp":1768919484,"startTime":"0","endTime":"0","summary":"1月20日，美股三大指数大幅低开，道琼斯指数跌1.28%，标普500指数跌1.33%，纳斯达克综合指数跌1.59%。明星科技股普跌，$英伟达(NVDA)$、$谷歌(GOOG)$、$亚马逊(AMZN)$、$博通(AVGO)$均跌超2%；$RAPT Therapeutics(RAPT)$涨超63%，$葛兰素史克(GSK)$将以58美元/股收购该公司；联电涨近14%，28纳米SuperFlash第四代车规1级平台投产；Critical Metals涨近7%，将与沙特工业集团成立合资公司扩大稀土供应。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b095a447c097a74e1fb79a312d43a775","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UMC",".DJI","CRML","RAPT"],"gpt_icon":0},{"id":"1128251074","title":"若协议终止，RAPT Therapeutics Inc.将向葛兰素史克支付7840万美元现金终止费","url":"https://stock-news.laohu8.com/highlight/detail?id=1128251074","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128251074?lang=zh_cn&edition=full","pubTime":"2026-01-20 19:15","pubTimestamp":1768907719,"startTime":"0","endTime":"0","summary":"根据协议条款，若发生特定终止事件，RAPT Therapeutics Inc.将需向制药巨头葛兰素史克支付一笔高达7840万美元的现金终止费用。此项安排凸显了双方合作协议中关于提前解约的财务约束机制。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1487256676.USD","LU0225284248.USD","LU0225771236.USD","LU1098665638.USD","LU1645745479.HKD","LU0109981661.USD","LU0211331839.USD","LU0971552830.HKD","LU1228905037.USD","LU1046248800.SGD","LU0985481810.HKD","IE0034235071.USD","LU1481599808.USD","LU1983299246.USD","LU1400636491.USD","IE00B3T34201.USD","LU0321505868.SGD","LU0545562505.USD","LU0289739699.SGD","LU1302929846.USD","LU1481600234.SGD","LU1670756490.USD","LU1064927863.SGD","BK5011","LU0161305163.EUR","LU0321505439.SGD","LU0575583348.USD","IE00BWDBJ516.SGD","LU1228905540.USD","IE00BQJZX424.USD","LU1035777561.USD","RAPT","LU0306807586.USD","GSK.UK","LU1400636657.SGD","LU0203345920.USD","LU1015430645.USD","LU0058720904.USD","LU0306806265.USD","LU1400636574.HKD","LU0971552673.USD","LU0203347892.USD","LU1202635105.USD","LU1309081286.SGD"],"gpt_icon":0},{"id":"1161994192","title":"盘前异动 | 特斯拉、英伟达等跌超2%；加密货币、AI应用概念股大跌；RAPT飙升63%，CRML涨超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1161994192","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161994192?lang=zh_cn&edition=full","pubTime":"2026-01-20 17:09","pubTimestamp":1768900143,"startTime":"0","endTime":"0","summary":"1月20日，美股三大股指期货齐跌，截止发稿，道指期货跌1.47%，纳指期货跌1.89%，标普500指数期货跌1.61%。明星科技股普跌，$特斯拉$、$英伟达$、$谷歌A$、$亚马逊$、$Meta Platforms$、$AMD$、$甲骨文$、$博通$、$英特尔$均跌超2%；加密货币概念股大跌，$BitMine$跌近7%，$CleanSpark$跌超6%，$Strategy$跌超5%，$Robinhood$跌超4%，$Circle$跌超3%；美股AI应用概念股集体下跌，$Rezolve AI$跌超11%，$AppLovin Corporation$跌超6%，$Tempus AI$、$SoundHound AI$跌超4%，$BigBear.ai Holdings$、$Unity Software$、$Figma$、$Shopify$跌超3%，$Palantir$、$Cerence Inc$、$C3.ai$跟跌。","market":"us","thumbnail":"https://static.tigerbbs.com/a7ed81b1e72df2f2f0f21497fe08eaed","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/a7ed81b1e72df2f2f0f21497fe08eaed"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b095a447c097a74e1fb79a312d43a775","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AG",".DJI","UMC",".IXIC","RAPT",".SPX","NVDA","TSLA"],"gpt_icon":0},{"id":"2604113507","title":"GSK 达成一笔 22 亿美元的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2604113507","media":"丁香园 Insight 数据库","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604113507?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:23","pubTimestamp":1768897383,"startTime":"0","endTime":"0","summary":"1 月 20 日，GSK 宣布已达成最终协议，收购 RAPT Therapeutics。截图来源：企业官网根据协议条款，GSK 将在交易完成时向 RAPT Therapeutics 股东支付每股 58.00 美元，预计总股权价值为22 亿美元。扣除收购的现金后，GSK 预计的前期投资为 19 亿美元。此次交易使GSK 获得 Ozureprubart 项目的全球权益，但不包括中国大陆、澳门、台湾和香港地区。GSK 还将负责向 RAPT 的合作伙伴济民可信支付Ozureprubart项目基于成功研发的里程碑付款和特许权使用费。该交易预计将于 2026 年第一季度完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120171645a4405fbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120171645a4405fbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","BK4007","BK4139","LU1829250122.USD","BK4585","GSK","GSK.UK","RAPT","BK4588"],"gpt_icon":0},{"id":"2604167450","title":"葛兰素史克将收购生物制药公司RAPT","url":"https://stock-news.laohu8.com/highlight/detail?id=2604167450","media":"南方财经网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604167450?lang=zh_cn&edition=full","pubTime":"2026-01-20 15:36","pubTimestamp":1768894560,"startTime":"0","endTime":"0","summary":"南方财经1月20日电，据界面新闻，葛兰素史克1月20日宣布，已同RAPTTherapeutics达成最终收购协议。RAPT是一家位于美国加州的临床阶段生物制药公司，致力于为患有炎症和免疫疾病的患者开发新型疗法。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b0ae671786534a1c4e2be67b7d225de0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601203624628683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4139","RAPT","BK4532","GSK","LU1829250122.USD","BK4585","GSK.UK","BK4007","BK4588"],"gpt_icon":0},{"id":"1117194686","title":"葛兰素史克与RAPT Therapeutics达成收购协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1117194686","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117194686?lang=zh_cn&edition=full","pubTime":"2026-01-20 15:11","pubTimestamp":1768893065,"startTime":"0","endTime":"0","summary":"1月20日，RAPT Therapeutics美股夜盘飙升近20%！葛兰素史克(GSK.N)：将以每股58美元收购Rapt，股权价值为22亿美元。预计前期投入资金为19亿美元。","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b0ae671786534a1c4e2be67b7d225de0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"葛兰素史克与RAPT Therapeutics达成收购协议","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK","RAPT"],"gpt_icon":0},{"id":"1190261155","title":"RAPT Therapeutics启动Ozureprubart（Rpt904）在食物过敏患者中的Prestige 2B期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1190261155","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190261155?lang=zh_cn&edition=full","pubTime":"2025-10-27 20:02","pubTimestamp":1761566577,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics启动Ozureprubart（Rpt904）在食物过敏患者中的Prestige 2B期临床试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RAPT"],"gpt_icon":0},{"id":"1156143109","title":"RAPT Therapeutics 股价因中国实验性皮肤病药物积极试验数据上涨 43.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1156143109","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1156143109?lang=zh_cn&edition=full","pubTime":"2025-10-20 21:33","pubTimestamp":1760967191,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics 股价因中国实验性皮肤病药物的积极试验数据上涨 43.2%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RAPT"],"gpt_icon":0},{"id":"1145187079","title":"RAPT Therapeutics股价在盘前交易中上涨95%，因中国临床试验数据显示实验性皮肤病药物效果良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1145187079","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145187079?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:51","pubTimestamp":1760964669,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics股价在盘前交易中上涨95%，因中国临床试验数据显示实验性皮肤病药物效果良好","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RAPT"],"gpt_icon":0},{"id":"1102462553","title":"RAPT Therapeutics与上海杰优制药宣布Rpt904(Jyb1904)在慢性自发性荨麻疹的Ⅱ期试验中取得积极初步数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1102462553","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102462553?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:01","pubTimestamp":1760961697,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics与上海杰优制药宣布Rpt904(Jyb1904)在慢性自发性荨麻疹的Ⅱ期试验中取得积极初步数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT","BK4139"],"gpt_icon":0},{"id":"1119022708","title":"RAPT Therapeutics将公布Rpt904在慢性自发性荨麻疹（Csu）二期临床试验的关键数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1119022708","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119022708?lang=zh_cn&edition=full","pubTime":"2025-10-19 20:01","pubTimestamp":1760875270,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics将公布Rpt904在慢性自发性荨麻疹（Csu）二期临床试验的关键数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RAPT"],"gpt_icon":0},{"id":"1189766339","title":"RAPT Therapeutics宣布FDA批准IND申请，将开展RPT904食物过敏2B期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1189766339","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189766339?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:08","pubTimestamp":1759136920,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics宣布FDA批准IND申请，将开展RPT904食物过敏2B期试验","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT","BK4139"],"gpt_icon":0},{"id":"1107402750","title":"RAPT Therapeutics股价盘前上涨3.1%，Leerink Partners将评级从\"市场表现\"上调至\"跑赢大盘\"","url":"https://stock-news.laohu8.com/highlight/detail?id=1107402750","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107402750?lang=zh_cn&edition=full","pubTime":"2025-09-26 18:47","pubTimestamp":1758883674,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics股价在盘前交易中上涨3.1%，此前Leerink Partners将该股评级从\"市场表现\"上调至\"跑赢大盘\"。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT","BK4139"],"gpt_icon":0},{"id":"2567145175","title":"Rapt Therapeutics, Inc.盘中异动 股价大涨5.67%报17.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567145175","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567145175?lang=zh_cn&edition=full","pubTime":"2025-09-15 23:05","pubTimestamp":1757948738,"startTime":"0","endTime":"0","summary":"北京时间2025年09月15日23时05分，Rapt Therapeutics, Inc.股票出现异动，股价快速上涨5.67%。Rapt Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Monte Rosa Therapeutics, Inc.、Apollomics Inc C/Wts 01/04/2028 、冠科美博涨幅较大，Salarius Pharmaceuticals, Inc.、Nucana Plc、Atyr Pharma, Inc.较为活跃，换手率分别为553.99%、99.02%、97.11%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、冠科美博、Cognition Therapeutics, Inc.，振幅分别为46.37%、38.07%、33.18%。Rapt Therapeutics, Inc.公司简介：RAPT Therapeutics Inc 是一家以免疫学为基础的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509152305389793d40a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202509152305389793d40a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","RAPT","LENZ","BK4539"],"gpt_icon":0},{"id":"2518281156","title":"Rapt Therapeutics, Inc.2024财年实现净利润-1.30亿美元，同比减少11.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518281156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518281156?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536074,"startTime":"0","endTime":"0","summary":"3月10日，Rapt Therapeutics, Inc.公布财报，公告显示公司2024财年净利润为-1.30亿美元，同比减少11.11%；其中营业收入为0.00美元，每股基本收益为-3.19美元。从资产负债表来看，Rapt Therapeutics, Inc.总负债50.42百万美元，其中短期债务2.42百万美元，资产负债比为0.05，流动比率为0.05。机构评级：截至2025年3月10日，当前有3家机构对Rapt Therapeutics, Inc.目标价做出预测，其中目标均价为6.00美元，其中最低目标价为2.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000223a2689865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000223a2689865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RAPT"],"gpt_icon":0},{"id":"1178508796","title":"RAPT Therapeutics 第四季度每股收益$(1.14)低于预期$(0.36)","url":"https://stock-news.laohu8.com/highlight/detail?id=1178508796","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178508796?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:46","pubTimestamp":1741268789,"startTime":"0","endTime":"0","summary":"RAPT Therapeutics（LENZ）第四季度每股收益为$(1.14)，低于预期的$(0.36)以上内容来自Benzinga Earnings专栏，原文如下：RAPT $Therapeutics(LENZ)$ Q4 EPS $(1.14) Misses $(0.36) Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"RAPT Therapeutics 第四季度每股收益$(1.14)低于预期$(0.36)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RAPT"],"gpt_icon":0},{"id":"2514305573","title":"Rapt Therapeutics, Inc.盘中异动 临近收盘大幅下跌5.13%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514305573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514305573?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:37","pubTimestamp":1740688665,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时37分，Rapt Therapeutics, Inc.股票出现异动，股价大幅下跌5.13%。Rapt Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.40%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1937.55%、397.06%、196.66%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Rapt Therapeutics, Inc.公司简介：RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228043746a256cb82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228043746a256cb82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RAPT"],"gpt_icon":0},{"id":"2512165418","title":"Rapt Therapeutics, Inc.盘中异动 快速上涨5.00%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165418?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:36","pubTimestamp":1739889366,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时36分，Rapt Therapeutics, Inc.股票出现异动，股价急速拉升5.00%。Rapt Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Solid Biosciences Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com涨幅较大，Aditxt, Inc.、Solid Biosciences Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为286.19%、100.98%、75.77%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Allogene Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为34.04%、22.30%、20.73%。Rapt Therapeutics, Inc.公司简介：RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223606abd3b040&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223606abd3b040&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RAPT","LENZ"],"gpt_icon":0},{"id":"2505028768","title":"Rapt Therapeutics, Inc.盘中异动 下午盘股价大跌5.33%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505028768","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505028768?lang=zh_cn&edition=full","pubTime":"2025-01-24 03:49","pubTimestamp":1737661767,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日03时49分，Rapt Therapeutics, Inc.股票出现波动，股价大幅下挫5.33%。Rapt Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，Dogwood Therapeutics, Inc.、Transcode Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.涨幅较大，Dogwood Therapeutics, Inc.、Hepion Pharmaceuticals, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为7034.83%、6475.63%、804.44%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Nutriband Inc C/Wts 、Hepion Pharmaceuticals, Inc.，振幅分别为948.57%、145.99%、119.04%。Rapt Therapeutics, Inc.公司简介：RAPT Therapeutics Inc 是一家基于临床阶段的免疫学生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240349279870f1ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501240349279870f1ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RAPT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rapt.com","stockEarnings":[{"period":"1week","weight":0.0016},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.7946},{"period":"6month","weight":4.1345},{"period":"1year","weight":5.3618},{"period":"ytd","weight":0.713}],"compareEarnings":[{"period":"1week","weight":0.0058},{"period":"1month","weight":-0.0081},{"period":"3month","weight":0.0071},{"period":"6month","weight":0.0662},{"period":"1year","weight":0.1552},{"period":"ytd","weight":0.0065}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"RAPT Therapeutics, Inc.根据特拉华州法律于2015年3月注册成立。该公司是一家临床阶段，以免疫学为基础的生物制药公司，致力于发现，开发和商业化针对在肿瘤学和炎性疾病方面尚未得到充分满足的患者的口服小分子疗法。利用其专有的药物发现和开发引擎，该公司开发了高度选择性小分子，旨在调节这些疾病的关键免疫反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.155572},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.193168},{"month":3,"riseRate":0.857143,"avgChangeRate":0.020044},{"month":4,"riseRate":0,"avgChangeRate":-0.16676},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.061242},{"month":6,"riseRate":0.666667,"avgChangeRate":0.216374},{"month":7,"riseRate":0.666667,"avgChangeRate":0.062663},{"month":8,"riseRate":0.666667,"avgChangeRate":0.042508},{"month":9,"riseRate":0.333333,"avgChangeRate":0.195895},{"month":10,"riseRate":0.5,"avgChangeRate":-0.027693},{"month":11,"riseRate":0.571429,"avgChangeRate":0.058369},{"month":12,"riseRate":0.857143,"avgChangeRate":0.169907}],"exchange":"NASDAQ","name":"RAPT Therapeutics, Inc.","nameEN":"RAPT Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RAPT Therapeutics, Inc.(RAPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供RAPT Therapeutics, Inc.(RAPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"RAPT Therapeutics, Inc.,RAPT,RAPT Therapeutics, Inc.股票,RAPT Therapeutics, Inc.股票老虎,RAPT Therapeutics, Inc.股票老虎国际,RAPT Therapeutics, Inc.行情,RAPT Therapeutics, Inc.股票行情,RAPT Therapeutics, Inc.股价,RAPT Therapeutics, Inc.股市,RAPT Therapeutics, Inc.股票价格,RAPT Therapeutics, Inc.股票交易,RAPT Therapeutics, Inc.股票购买,RAPT Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RAPT Therapeutics, Inc.(RAPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供RAPT Therapeutics, Inc.(RAPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}